Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Show me how to use this page

Walgreens Boots Alliance Inc. Stock

Price
Target price
€10.07

€10.07

-0.980%
-0.1
-0.980%
€8.50
 
01.08.25 / Tradegate WKN: A12HJF / Symbol: WBA / Name: Walgreens Boots / Stock / Food & Drug Retailing / Large Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Walgreens Boots Alliance Inc. in the next few years
Wizard

Walgreens Boots Alliance Inc. Stock

The price for the Walgreens Boots Alliance Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.100 (-0.980%).
With 5 Buy predictions and 6 Sell predictions the community is currently undecided on Walgreens Boots Alliance Inc..
A potential of -20.52%, resulting from comparing the current price of 10.07 € with the target price of 8 € for Walgreens Boots Alliance Inc., shows the chance of incurring significant losses.
So far the community has only identified positive things for Walgreens Boots Alliance Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Walgreens Boots Alliance (Symbol: WBA) (WKN: A12HJF) is a leading global pharmacy retail and healthcare company, listed on the stock exchange, with a presence in several countries worldwide. Founded in 2014 following the merger of Walgreens and Alliance Boots, the company's operations span across three core divisions: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. As a pioneer in the pharmacy sector, WBA offers a diverse range of products and services, including prescription medications, over-the-counter drugs, beauty and personal care items, as well as various in-store health services. Its extensive network of physical locations and innovative e-commerce platforms enables WBA to reach millions of customers, while also participating in strategic joint ventures and partnerships to strengthen its market position. With a strong commitment to social responsibility and sustainability, Walgreens Boots Alliance has positioned itself as a major player in the ever-evolving global healthcare landscape, dedicated to improving the lives of the communities it serves.

Pros and Cons of Walgreens Boots Alliance Inc. in the next few years

Pros
?
S********** s********
?
G***** c******* t* c**********
?
B****
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

Performance of Walgreens Boots Alliance Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Walgreens Boots Alliance Inc. -0.980% 1.656% 3.432% -7.989% 8.904% -74.117% -70.878%
CVS Health Corp. -1.180% 4.429% -8.507% -2.948% 26.990% -42.318% 1.029%
Cardinal Health Inc. -1.400% 0.747% -3.299% 40.703% 19.231% 129.337% 190.876%
McKesson Corp. -0.160% -0.462% -2.172% 3.533% 9.745% 80.800% 374.678%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

When diving into the financials of Walgreens Boots Alliance (WBA), a nuanced picture emerges. The company, an established name in the Food & Drug Retailing sector, presents a mix of alarming challenges and notable strengths as it navigates an increasingly competitive market landscape. While facing recent struggles highlighted by inconsistent earnings and fluctuating revenues, some metrics offer a glimpse of resilience, particularly in efforts to enhance operational efficiency and maintain shareholder value.

Examining the financials reveals several pros and cons:

*Pros: *

Show more

Comments

Prediction Sell
Perf. (%) -3.21%
Target price 8.646
Change
Ends at 28.02.26

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "sell" rating. They now have a $9.00 price target on the stock, down previously from $11.00.
Ratings data for WBA provided by MarketBeat
Show more

Deutsche Bank Aktiengesellschaft 
0
Report Share
28.02.25
Prediction Sell
Perf. (%) -12.45%
Target price 8.324
Change
Ends at 13.01.26

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) had its price target raised by analysts at Bank of America Co. from $7.50 to $8.50. They now have an "underperform" rating on the stock.
Ratings data for WBA provided by MarketBeat
Show more

Bank of America Co. 
0
Report Share
13.01.25
Prediction Buy
Perf. (%) 8.43%
Target price 12.944
Change
Ends at 22.10.25

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) had its price target lowered by analysts at TD Cowen from $16.00 to $14.00. They now have a "buy" rating on the stock.
Ratings data for WBA provided by MarketBeat
Show more

TD Cowen 
0
Report Share
22.10.24
Show more
Not a member yet? Sign up for free!

News

Walgreens Boots Alliance Stock: Sycamore Partners Plans $23.7B Acquisition
Walgreens Boots Alliance Stock: Sycamore Partners Plans $23.7B Acquisition

Walgreens Boots Alliance is poised for a significant transformation as private equity firm Sycamore Partners proposes a $23.7 billion (€22.1 billion) deal to take the pharmacy chain private

StockWorldEnglish 
0 07.03.25